Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 322,768 | 262,707 | 333,197 | 372,152 | 414,690 |
| Marketable Securities | 1,437,396 | 1,356,427 | 1,304,624 | 1,139,620 | 972,533 |
| Receivables | 852,902 | 742,446 | 610,804 | 597,397 | 500,751 |
| Inventories | 559,920 | 527,649 | 524,729 | 469,640 | 423,439 |
| Income taxes - deferred | N/A | N/A | N/A | 121,885 | N/A |
| TOTAL | $3,376,467 | $3,056,384 | $2,950,266 | $2,780,136 | $2,594,321 |
| Non-Current Assets | |||||
| PPE Net | 1,922,313 | 1,740,423 | 1,679,549 | 1,617,912 | 1,540,849 |
| Investments And Advances | 1,310,422 | 1,414,663 | 1,654,985 | 1,422,886 | 1,306,143 |
| Intangibles | 1,992,068 | 2,025,663 | 2,080,434 | 2,125,829 | 2,161,328 |
| Other Non-Current Assets | 776,576 | 817,906 | 769,221 | 812,714 | 793,104 |
| TOTAL | $6,001,379 | $5,998,655 | $6,184,189 | $5,979,341 | $5,801,424 |
| Total Assets | $9,377,846 | $9,055,039 | $9,134,455 | $8,759,477 | $8,395,745 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 60,081 | 30,326 | 24,296 | 59,700 | 66,479 |
| Other current liabilities | 848,825 | 806,550 | 663,312 | N/A | N/A |
| TOTAL | $1,081,042 | $836,876 | $687,608 | $896,337 | $786,043 |
| Non-Current Liabilities | |||||
| Long Term Debt | 412,250 | 412,250 | 412,250 | 412,250 | 412,250 |
| Deferred Revenues | N/A | N/A | N/A | 47,478 | N/A |
| Other Non-Current Liabilities | 916,988 | 920,879 | 927,347 | 649,349 | 670,475 |
| TOTAL | $1,329,238 | $1,333,129 | $1,339,597 | $1,342,842 | $1,365,656 |
| Total Liabilities | $2,410,280 | $2,170,005 | $2,027,205 | $2,239,179 | $2,151,699 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,049,622 | 1,054,316 | 1,063,578 | 1,054,058 | 1,046,397 |
| Common Shares | 21,088 | 21,141 | 10,612 | 20,990 | 10,444 |
| Retained earnings | -1,290,777 | -1,276,462 | -980,904 | -1,157,141 | -1,279,139 |
| Other shareholders' equity | 291,412 | 292,117 | 326,148 | 297,033 | 299,148 |
| TOTAL | $6,967,566 | $6,885,034 | $7,107,250 | $6,520,298 | $6,244,046 |
| Total Liabilities And Equity | $9,377,846 | $9,055,039 | $9,134,455 | $8,759,477 | $8,395,745 |